Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells

Masayuki Matsui, Richard N. Threlfall, Marvin H. Caruthers, David R. Corey

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Optimizing oligonucleotides as therapeutics will require exploring how chemistry can be used to enhance their effects inside cells. To achieve this goal it will be necessary to fully explore chemical space around the native DNA/RNA framework to define the potential of diverse chemical modifications. In this report we examine the potential of thiophosphonoacetate (thioPACE)-modified 2'-O-methyl oligoribonucleotides as inhibitors of human huntingtin (HTT) expression. Inhibition occurred, but was less than with analogous locked nucleic acid (LNA)-substituted oligomers lacking the thioPACE modification. These data suggest that thioPACE oligonucleotides have the potential to control gene expression inside cells. However, advantages relative to other modifications were not demonstrated. Additional modifications are likely to be necessary to fully explore any potential advantages of thioPACE substitutions.

Original languageEnglish (US)
Pages (from-to)e1146391
JournalArtificial DNA, PNA & XNA
Volume5
Issue number3
DOIs
StatePublished - Dec 15 2014

Fingerprint

Antisense Oligonucleotides
Oligonucleotides
Oligoribonucleotides
Chemical modification
Oligomers
Gene expression
Substitution reactions
RNA
Gene Expression
DNA
Therapeutics
locked nucleic acid

Keywords

  • antisense oligonucleotides
  • huntingtin
  • Huntington's disease
  • locked nucleic acids
  • phosphate modification
  • thiophosphonoacetate

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry

Cite this

Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells. / Matsui, Masayuki; Threlfall, Richard N.; Caruthers, Marvin H.; Corey, David R.

In: Artificial DNA, PNA & XNA, Vol. 5, No. 3, 15.12.2014, p. e1146391.

Research output: Contribution to journalArticle

@article{e255bbb41fd641dbb2ecbc9957c77a37,
title = "Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells",
abstract = "Optimizing oligonucleotides as therapeutics will require exploring how chemistry can be used to enhance their effects inside cells. To achieve this goal it will be necessary to fully explore chemical space around the native DNA/RNA framework to define the potential of diverse chemical modifications. In this report we examine the potential of thiophosphonoacetate (thioPACE)-modified 2'-O-methyl oligoribonucleotides as inhibitors of human huntingtin (HTT) expression. Inhibition occurred, but was less than with analogous locked nucleic acid (LNA)-substituted oligomers lacking the thioPACE modification. These data suggest that thioPACE oligonucleotides have the potential to control gene expression inside cells. However, advantages relative to other modifications were not demonstrated. Additional modifications are likely to be necessary to fully explore any potential advantages of thioPACE substitutions.",
keywords = "antisense oligonucleotides, huntingtin, Huntington's disease, locked nucleic acids, phosphate modification, thiophosphonoacetate",
author = "Masayuki Matsui and Threlfall, {Richard N.} and Caruthers, {Marvin H.} and Corey, {David R.}",
year = "2014",
month = "12",
day = "15",
doi = "10.1080/1949095X.2016.1146391",
language = "English (US)",
volume = "5",
pages = "e1146391",
journal = "Artificial DNA: PNA and XNA",
issn = "1949-095X",
publisher = "Landes Bioscience",
number = "3",

}

TY - JOUR

T1 - Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells

AU - Matsui, Masayuki

AU - Threlfall, Richard N.

AU - Caruthers, Marvin H.

AU - Corey, David R.

PY - 2014/12/15

Y1 - 2014/12/15

N2 - Optimizing oligonucleotides as therapeutics will require exploring how chemistry can be used to enhance their effects inside cells. To achieve this goal it will be necessary to fully explore chemical space around the native DNA/RNA framework to define the potential of diverse chemical modifications. In this report we examine the potential of thiophosphonoacetate (thioPACE)-modified 2'-O-methyl oligoribonucleotides as inhibitors of human huntingtin (HTT) expression. Inhibition occurred, but was less than with analogous locked nucleic acid (LNA)-substituted oligomers lacking the thioPACE modification. These data suggest that thioPACE oligonucleotides have the potential to control gene expression inside cells. However, advantages relative to other modifications were not demonstrated. Additional modifications are likely to be necessary to fully explore any potential advantages of thioPACE substitutions.

AB - Optimizing oligonucleotides as therapeutics will require exploring how chemistry can be used to enhance their effects inside cells. To achieve this goal it will be necessary to fully explore chemical space around the native DNA/RNA framework to define the potential of diverse chemical modifications. In this report we examine the potential of thiophosphonoacetate (thioPACE)-modified 2'-O-methyl oligoribonucleotides as inhibitors of human huntingtin (HTT) expression. Inhibition occurred, but was less than with analogous locked nucleic acid (LNA)-substituted oligomers lacking the thioPACE modification. These data suggest that thioPACE oligonucleotides have the potential to control gene expression inside cells. However, advantages relative to other modifications were not demonstrated. Additional modifications are likely to be necessary to fully explore any potential advantages of thioPACE substitutions.

KW - antisense oligonucleotides

KW - huntingtin

KW - Huntington's disease

KW - locked nucleic acids

KW - phosphate modification

KW - thiophosphonoacetate

UR - http://www.scopus.com/inward/record.url?scp=85015141889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015141889&partnerID=8YFLogxK

U2 - 10.1080/1949095X.2016.1146391

DO - 10.1080/1949095X.2016.1146391

M3 - Article

C2 - 26865404

AN - SCOPUS:85015141889

VL - 5

SP - e1146391

JO - Artificial DNA: PNA and XNA

JF - Artificial DNA: PNA and XNA

SN - 1949-095X

IS - 3

ER -